Policy Matters| Volume 31, ISSUE 3, P219-226, May 2021

Contraceptive Method Uptake at Title X Health Centers in Utah

Published:March 06, 2021DOI:



      The Title X family planning program previously supported contraception for Utah clients with low incomes, yet its contributions may not have been sufficient to allow clients to select their preferred methods, including long-acting reversible contraceptives (LARCs). In this study, we compare the contraceptive method choices of self-paying clients with low incomes at three participating Title X health centers in Salt Lake County, Utah, before and after the removal of additional cost barriers.


      We used retrospective medical record review to assess clients’ contraceptive choices during two 6-month periods: a control period with Title X-assisted sliding scale payment schedules (n = 2,776) and an intervention period offering no-cost contraceptive care (n = 2,065). We used logistic regression to identify the likelihood of selecting a LARC during the intervention period and multinomial regression to identify the selection probability of different types of available LARCs.


      During the control period, 16% of participants chose a LARC compared with 26% in the intervention period (p ≤ .001). During the intervention period, participants were 1.8 times more likely to select LARCs (95% confidence interval, 1.65–2.13) compared with non-LARC methods, holding covariates constant. In the multinomial regression, participants were three times more likely during the intervention period to select an implant than a pill, patch, or ring, holding all other covariates constant (odds ratio, 3.08; 95% confidence interval, 2.47–3.83).


      Title X clients offered contraceptive methods without cost more frequently selected a LARC method. Title X funding reductions may impede individuals’ access to their contraceptive methods of choice.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Women's Health Issues
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Akers A.Y.
        • Harding J.
        • Perriera L.K.
        • Schreiber C.
        • Garcia-Espana J.F.
        • Sonalkar S.
        Satisfaction with the intrauterine device insertion procedure among adolescent and young adult women.
        Obstetrics and Gynecology. 2018; 131: 1130-1136
        • Berchick E.R.
        • Barnett J.C.
        • Upton R.D.
        Health insurance coverage in the United States: 2018. United States Census Bureau.
        • Birgisson N.E.
        • Zhao Q.
        • Secura G.M.
        • Madden T.
        • Peipert J.F.
        Preventing unintended pregnancy: The contraceptive CHOICE project in review.
        Journal of Women's Health. 2015; 23: 349-353
        • Blumenthal D.
        • Collins S.
        Health care coverage under the Affordable Care Act—A progress report.
        New England Journal of Medicine. 2014; 371: 275-281
        • Boudreaux M.
        • Xie L.
        • Choi Y.S.
        • Roby D.H.
        • Rendall M.S.
        Changes to contraceptive method use at Title X clinics following Delaware contraceptive access now, 2008–2017.
        American Journal of Public Health. 2020; 110: 1214-1220
        • Castañeda H.
        • Mulligan J.M.
        Unequal coverage: The experience of health care reform in the United States.
        New York University Press, New York2018
        • Dawson R.
        Trump administration's domestic gag rule has slashed the Title X network's capacity by half. Guttmacher Institute.
        • Dehlendorf C.
        • Diedrich J.
        • Drey E.
        • Postone A.
        • Steinauer J.
        Preferences for decision-making about contraception and general health care among reproductive age women at an abortion clinic.
        Patient Education and Counseling. 2010; 81: 343-348
        • Dehlendorf C.
        • Krajewski C.
        • Borrero S.
        Contraceptive counseling: Best practices to ensure quality communication and enable effective contraceptive use.
        Clinical Obstetrics and Gynecology. 2014; 57: 659-673
        • Early D.R.
        • Dove M.S.
        • Thiel de Bocanegra H.
        • Schwarz E.B.
        Publicly funded family planning: Lessons from California, before and after the ACA’s Medicaid expansion.
        Health Affairs. 2018; 37: 1475-1483
        • Eisenberg D.
        • McNicholas C.
        • Peipert J.F.
        Cost as a barrier to long-acting reversible contraceptive (LARC) use in adolescents.
        Journal of Adolescent Health. 2013; 52: S59-S63
        • Foster D.G.
        • Barar R.
        • Gould H.
        • Gomez I.
        • Nguyen D.
        • Biggs M.A.
        Projections and opinions from 100 experts in long-acting reversible contraception.
        Contraception. 2015; 92: 543-552
        • Goldin Evans M.
        • Broyles S.
        • Frederiksen B.
        • Gee R.E.
        • Phillippi S.
        • Sothern M.
        • Wightkin J.
        Long-acting reversible contraceptive utilization after policy change increasing device reimbursement to wholesale acquisition cost in Louisiana.
        American Journal of Obstetrics and Gynecology. 2019; 221 (128.e1–128.e10)
        • Goodman M.
        • Onwumere O.
        • Milam L.
        • Peipert J.F.
        Reducing health disparities by removing cost, access, and knowledge barriers.
        American Journal of Obstetrics and Gynecology. 2017; 216 (82.e1–383.e5)
        • Heinemann K.
        • Reed S.
        • Moehner S.
        • Do Minh T.
        Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: The European Active Surveillance Study for Intrauterine Devices.
        Contraception. 2015; 91: 280-283
        • Hubacher D.
        • Chen P.-L.
        • Park S.
        Side effects from the copper IUD: Do they decrease over time?.
        Contraception. 2009; 79: 356-362
        • Hubacher D.
        • Spector H.
        • Monteith C.
        • Chen P.L.
        • Hart C.
        Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception.
        Contraception. 2015; 91: 185-192
        • Jerman J.
        • Frohwirth L.
        • Kavanaugh M.L.
        • Blades N.
        Barriers to abortion care and their consequences for patients traveling for services: Qualitative findings from two states.
        Perspectives on Sexual and Reproductive Health. 2017; 45: 95-102
        • Kavanaugh M.L.
        • Jerman J.
        Contraceptive method use in the United States: Trends and characteristics between 2008, 2012 and 2014.
        Contraception. 2018; 97: 14-21
        • Kavanaugh M.L.
        • Jerman J.
        • Finer L.B.
        Changes in use of long-acting reversible contraceptive methods among U.S. women, 2009-2012.
        Obstetrics and Gynecology. 2015; 126: 917-927
        • Kavanaugh M.L.
        • Zolna M.R.
        • Burke K.L.
        Use of health insurance among clients seeking contraceptive services at Title X-funded facilities in 2016.
        Perspectives on Sexual and Reproductive Health. 2018; 50: 101-109
        • Makoul G.
        • Clayman M.L.
        An integrative model of shared decision making in medical encounters.
        Patient Education and Counseling. 2006; 60: 301-312
        • Malat J.
        Racial differences in Norplant use in the United States.
        Social Science & Medicine. 2000; 50: 1297-1308
        • Mestad R.
        • Secura G.
        • Allsworth J.E.
        • Madden T.
        • Zhao Q.
        • Peipert J.F.
        Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project.
        Contraception. 2011; 84: 493-498
        • Moniz M.
        • Chang T.
        • Heisler M.
        • Dalton V.K.
        Immediate postpartum long-acting reversible contraception: The time is now.
        Contraception. 2017; 95: 335-338
        • O'Neil-Callahan M.
        • Peipert J.F.
        • Zhao Q.
        • Madden T.
        • Secura G.
        Twenty-four-month continuation of reversible contraception.
        Obstetrics and Gynecology. 2013; 122: 1083-1091
        • Pilliod R.A.
        • Caughey A.B.
        636: Uninsured births under the Affordable Care Act.
        American Journal of Obstetrics and Gynecology. 2018; 218: S379
        • Potter J.
        • Rubin S.E.
        • Sherman P.
        Fear of intrauterine contraception among adolescents in New York City.
        Contraception. 2014; 89: 446-450
        • Ricciotti H.A.
        • Dodge L.E.
        • Ramirez C.I.
        • Barnes K.
        • Hacker M.R.
        Long-acting reversible contraceptive use in urban women from a Title X–supported Boston community health center.
        Journal of Primary Care & Community Health. 2015; : 111-115
        • Ricketts S.
        • Klingler G.
        • Schwalberg R.
        Game change in Colorado: Widespread use of long-acting reversible contraceptives and rapid decline in births among young, low-income women.
        Perspectives on Sexual and Reproductive Health. 2014; 46: 125-132
        • Singh R.H.
        • Rogers R.G.
        • Leeman L.
        • Borders N.
        • Highfill J.
        • Espey E.
        Postpartum contraceptive choices among ethnically diverse women in New Mexico.
        Contraception. 2014; 89: 512-515
        • StataCorp
        Stata statistical software.
        StataCorp, LLC, College Station TX2017
        • Tang J.
        • Maurer R.
        • Bartz D.
        Intrauterine device knowledge and practices: A national survey of obstetrics and gynecology residents.
        Southern Medical Journal. 2013; 106: 500-505
        • Thompson K.M.J.
        • Speidel J.J.
        • Saporta V.
        • Waxman N.J.
        • Harper C.C.
        Contraceptive policies affect post-abortion provision of long-acting reversible contraception.
        Contraception. 2011; 83: 41-47
        • U.S. Department of Health and Human Services
        HHS releases final Title X rule detailing family planning grant program.


      Corinne Sexsmith, MS, is a Clinical Research Coordinator, University of Utah, with a background in the nonprofit sector. Corinne received her Master's in Human Development and Social Policy and is passionate about implementation research and promoting women's health in the community.


      Jessica Sanders, PhD, MSPH, is an Assistant Professor in Obstetrics and Gynecology, University of Utah. Using a public health lens, Dr. Sanders conducts and advocates for the use of interdisciplinary academic and clinical research to inform evidence-based policy in Utah and beyond.


      Rebecca G. Simmons, PhD, MPH, is a public health scientist with expertise in evaluating implementation interventions around sexual/reproductive health in domestic and global settings. She conducts research assessing how contraceptive use and needs change over the life course and fertility-awareness based methods.


      Cristen Dalessandro, PhD, is a sociologist and postdoctoral fellow in Family Planning at the University of Utah. Her previous publications and research have focused on the sexual health and intimate relationship lives of young adults.


      David Turok, MD, MPH, is an Associate Professor who directs the Division of Family Planning, University of Utah. He is the principal investigator of several NIH, industry, and foundation grants focusing on overcoming barriers to contraception and developing new contraceptive methods.